FDA Inspection 1237545 — Qingdao BAHEAL Pharmaceutical Co.,Ltd.
The FDA completed an inspection of Qingdao BAHEAL Pharmaceutical Co.,Ltd. on March 22, 2024 in Qingdao. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- March 22, 2024
- Fiscal Year
- 2024
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Qingdao (China)